Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatin versus Norditropin in children with growth hormone deficiency
IRCT20171122037571N1Phase 3Completed
- Sponsor
- AryaTinaGene
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in growth hormone deficiency (GHD) comparing Somatin with Norditropin (2 arms). Primary endpoint: Height velocity in the first year after treatment. Started May 2020; status: completed.
02
Drugs
somatostatinsomatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on IRCT20171122037571N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171122037571N1.